Multilocus Sequence Typing Reveals Genetic Diversity of Carbapenem- or Ceftazidime-Nonsusceptible Pseudomonas aeruginosa in China
Author(s) -
Jingshu Ji,
Jie Wang,
Zhihui Zhou,
Haiping Wang,
Yan Jiang,
Yunsong Yu
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00970-13
Subject(s) - multilocus sequence typing , pseudomonas aeruginosa , biology , meropenem , ceftazidime , microbiology and biotechnology , genetic diversity , genetics , imipenem , clone (java method) , carbapenem , allele , sequence (biology) , ceftazidime/avibactam , typing , genotype , gene , antibiotic resistance , antibiotics , bacteria , medicine , population , environmental health
It is unclear whether the genetic background of drug-resistant Pseudomonas aeruginosa was disseminated from a certain clone. Thus, we performed MLST (multilocus sequence typing) of 896 P. aeruginosa isolates that were nonsusceptible to imipenem, meropenem, or ceftazidime. This revealed 254 sequence types (STs), including 104 new STs and 34 STs with novel alleles. Thirty-three clonal complexes and 404 singletons were found. In conclusion, drug-resistant P. aeruginosa clones can be developed from diverse genetic backgrounds.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom